Liu et al. looked to exploit the specific chemokines and cytokines in the TME by developing a GDPC3 CAR modified to express CXCR2, which is highly expressed in human hepatocellular carcinoma (HCC). Here, CXCR2 is linked to hepatocellular carcinoma.